Christopher G Naveschuk
6PUBLICATIONS
39CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Nov 24, 2025
Discovery of CFT8634, a Potent, Selective, and Orally Bioavailable Heterobifunctional Degrader of BRD9.Katrina L Jackson, Ning Yin, Roman V Agafonov
|Oct 28, 2025
CFT1946 Is an Orally Available Brain-Penetrant BRAFV600-Mutant Degrader That Overcomes BRAF Inhibitor Resistance.Bridget T Kreger, Yanke Liang, Nicole M Reilly
|Aug 16, 2024
Mechanistic insights into a heterobifunctional degrader-induced PTPN2/N1 complex.Qi Hao, Manoj K Rathinaswamy, Kelly L Klinge
|Aug 05, 2022
GNE-064: A Potent, Selective, and Orally Bioavailable Chemical Probe for the Bromodomains of SMARCA2 and SMARCA4 and the Fifth Bromodomain of PBRM1.Alexander M Taylor, Chris Bailey, Lisa D Belmont
|Dec 30, 2021
Preclinical Development of the Class-I-Selective Histone Deacetylase Inhibitor OKI-179 for the Treatment of Solid Tumors.Jennifer R Diamond, Todd M Pitts, Dana Ungermannova
|Sep 28, 2021
Structural Characterization of Degrader-Induced Ternary Complexes Using Hydrogen-Deuterium Exchange Mass Spectrometry and Computational Modeling: Implications for Structure-Based Design.Scott J Eron, Hongwei Huang, Roman V Agafonov
Pageof 1
Frequent Collaborators
2 joint publications
Scott J Eron
2 joint publications
Roman V Agafonov
2 joint publications
Katrina L Jackson
1 joint publications
Brian Gittleman
1 joint publications
Michael K Wendt
1 joint publications
William P Schiemann
1 joint publications
Kevin DeMent
1 joint publications
Jeremy Murray
1 joint publications
Mathew E Sowa
1 joint publications
Andrea G Cochran
